- Home
- CERS vs MVT Comparison
CERS vs MVT Comparison
Compare CERS & MVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- MVT
- Stock Information
- Founded
- CERS 1991
- MVT 1993
- Country
- CERS United States
- MVT United States
- Employees
- CERS N/A
- MVT N/A
- Industry
- CERS EDP Services
- MVT Investment Bankers/Brokers/Service
- Sector
- CERS Technology
- MVT Finance
- Exchange
- CERS Nasdaq
- MVT Nasdaq
- Market Cap
- CERS 265.7M
- MVT 213.4M
- IPO Year
- CERS 1997
- MVT N/A
- Fundamental
- Price
- CERS $1.24
- MVT $10.13
- Analyst Decision
- CERS Strong Buy
- MVT
- Analyst Count
- CERS 2
- MVT 0
- Target Price
- CERS $3.50
- MVT N/A
- AVG Volume (30 Days)
- CERS 1.2M
- MVT 49.7K
- Earning Date
- CERS 08-05-2025
- MVT 01-01-0001
- Dividend Yield
- CERS N/A
- MVT 4.15%
- EPS Growth
- CERS N/A
- MVT N/A
- EPS
- CERS N/A
- MVT N/A
- Revenue
- CERS $192,510,000.00
- MVT N/A
- Revenue This Year
- CERS $24.95
- MVT N/A
- Revenue Next Year
- CERS $11.88
- MVT N/A
- P/E Ratio
- CERS N/A
- MVT N/A
- Revenue Growth
- CERS 13.25
- MVT N/A
- 52 Week Low
- CERS $1.12
- MVT $8.96
- 52 Week High
- CERS $2.39
- MVT $11.17
- Technical
- Relative Strength Index (RSI)
- CERS 41.74
- MVT 49.55
- Support Level
- CERS $1.25
- MVT $10.13
- Resistance Level
- CERS $1.38
- MVT $10.32
- Average True Range (ATR)
- CERS 0.07
- MVT 0.09
- MACD
- CERS -0.00
- MVT 0.01
- Stochastic Oscillator
- CERS 15.79
- MVT 52.50
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About MVT Blackrock MuniVest Fund II Inc.
Blackrock Munivest Fund II Inc is a closed-end management investment company. The fund's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Health, Utilities, Education, Housing, and other sectors.